surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection手术的结果cytoreductive手术的原发性腹膜癌患者使用一个名为aqua解剖的新技术.pdfVIP

Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2012, Article ID 521487, 10 pages doi:10.1155/2012/521487 Clinical Study Surgical Results of Patients with Peritoneal Carcinomatosis Treated with Cytoreductive Surgery Using a New Technique Named Aqua Dissection Y. Yonemura,1, 2, 3 A. Elnemr,1 Y. Endou,4 H. Ishibashi,1, 3 A. Mizumoto,2 M. Miura,5 and Yan Li6 1 NPO Organization to Support Peritoneal Surface Malignancy Treatment, 1-26, Haruki-Moto-Machi, Kishiwada, Osaka, Japan 2 Department of Surgery, Kusatsu General Hospital, Shiga, Japan 3 Department of Surgery, Peritoneal Surface Malignancy Center, Kishiwada Tokushukai Hospital, Kishiwada, Japan 4 Department of Experimental Therapeutics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan 5 Department of Anatomy, School of Medicine, Oita University, Oita, Japan 6 Department of Oncology, Zhongnam Hospital and Cancer Center, Wuhan University, Wuhan, China Correspondence should be addressed to Y. Yonemura, y.yonemura@coda.ocn.ne.jp Received 14 January 2012; Accepted 11 March 2012 Academic Editor: Pompiliu Piso Copyright © 2012 Y. Yonemura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. During 2004 to 2011, 81, 420, and 166 patients with colorectal cancer (CRC), epithelial appendiceal neoplasm (APN), and gastric cancer (GC) with PC were treated with cytoreductive surgery (CRS) plus perioperative chemotherapy. CRS was performed by peritonectomy techniques using an aqua dissection. Results. Complete cytoreduction was done in 62/81 (76.5%), 228/420 (54.3%), and 101/166 (60.8%) of patients with CRC, APN,